Success Metrics

Clinical Success Rate
95.8%

Based on 1,321 completed trials

Completion Rate
96%(1321/1379)
Active Trials
526(20%)
Results Posted
9%(125 trials)
Terminated
58(2%)

Phase Distribution

Ph phase_4
22
1%
Ph phase_1
15
1%
Ph early_phase_1
4
0%
Ph not_applicable
270
10%
Ph phase_2
15
1%
Ph phase_3
14
1%

Phase Distribution

19

Early Stage

15

Mid Stage

36

Late Stage

Phase Distribution340 total trials
Early Phase 1First-in-human
4(1.2%)
Phase 1Safety & dosage
15(4.4%)
Phase 2Efficacy & side effects
15(4.4%)
Phase 3Large-scale testing
14(4.1%)
Phase 4Post-market surveillance
22(6.5%)
N/ANon-phased studies
270(79.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.2%

1321 of 1464 finished

Non-Completion Rate

9.8%

143 ended early

Currently Active

526

trials recruiting

Total Trials

2,664

all time

Status Distribution
Active(683)
Completed(1321)
Terminated(143)
Other(517)

Detailed Status

Completed1321
unknown513
Recruiting409
Not yet recruiting122
Active, not recruiting117
Withdrawn85

Development Timeline

Analytics

Development Status

Total Trials
2664
Active
526
Success Rate
95.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (1.2%)
Phase 115 (4.4%)
Phase 215 (4.4%)
Phase 314 (4.1%)
Phase 422 (6.5%)
N/A270 (79.4%)

Trials by Status

recruiting40915%
enrolling_by_invitation351%
completed132150%
not_yet_recruiting1225%
unknown51319%
withdrawn853%
suspended40%
terminated582%
active_not_recruiting1174%

Recent Activity

Clinical Trials (2,664)

Showing 20 of 2,664 trialsScroll for more
NCT07313176

Long Term Effectiveness of Levodopa-Entacapone-Carbidopa Intestinal Gel in Participants With Advanced Parkinson's Disease

Terminated
NCT07353099

A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated With Adzynma

Recruiting
NCT07855562

MPS IIIA Disease Monitoring Program

Not Yet Recruiting
NCT04537416

Fertility, Hypercoagulability, and Inflammation (FREYA) Registry

Active Not Recruiting
NCT06437132

Decoding Death and Dying in People With Dementia by Digital Thanotyping

Enrolling By Invitation
NCT06272123

Endotypic Stability in CRS

Active Not Recruiting
NCT07554573Phase 3

Assessment of Biosignature Classification of DCIS for RadioTherapy Benefit Post Lumpectomy (ABCD RT)

Not Yet Recruiting
NCT06581146

A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle Condition

Recruiting
NCT07840859Not Applicable

Clinical Effectiveness of Oxygen-Releasing Oral Gel as an Adjunct to Scaling and Root Debridement in Patients With Severe Periodontal Pockets: A Randomized Clinical Trial

Not Yet Recruiting
NCT07847372

Normative Values for Instrumented Gaze Stabilization Test and Dynamic Visual Acuity Test Following Fatigue

Completed
NCT06434506

Prevalence of the Wire Syndrome

Completed
NCT07841834

Assessment of Urinary Microplastic Concentration in Patients With Urolithiasis: A Prospective Case-Control Study

Not Yet Recruiting
NCT07516483Not Applicable

Thermal Preconditioning in Mastectomy Patients With Immediate Breast Reduction

Not Yet Recruiting
NCT05160584

A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma

Recruiting
NCT04805021

Acquired Hemophilia A and Autoimmunity. Study of Lymphocyte Populations and Myeloid-Derived Suppressor Cells

Completed
NCT07792148Not Applicable

Adapting the ESTEEM Intervention to Improve Mental Health and PrEP Uptake Among Men at Risk of HIV

Not Yet Recruiting
NCT07822971

Impact of an On-site Simulation-based Training Programme on Adherence to Standard Precautions and Healthcare-associated Infections in Adult Intensive Care

Recruiting
NCT04810702

Impact of Von Willebrand Factor and Its Multimers on Angiogenesis

Completed
NCT06143514

A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk

Active Not Recruiting
NCT07490431

An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Symptoms in United States

Not Yet Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
2,664